论文部分内容阅读
目的:探讨米索前列醇配合缩宫素预防产后出血临床价值。方法:本次研究中,选取我院于2014年5月至2016年5月期间诊治的90例自然分娩产妇为研究对象,按照抽签的形式分为参照组(45例)和实验组(45例),参照组给予产妇缩宫素预防产后出血,实验组患者则在此基础上配合米索前列醇预防产妇产后出血,对比两患者实际应用效果。结果:实验组产妇治疗效果明显优于参照组,子宫收缩明显改善,出血量不断减少。结论:米索前列醇配合缩宫素可以有效预防产妇产后出血,建议临床推广应用。
Objective: To investigate the clinical value of misoprostol combined with oxytocin in preventing postpartum hemorrhage. Methods: In this study, 90 cases of spontaneous labor in our hospital from May 2014 to May 2016 were selected and divided into two groups: control group (45 cases) and experimental group (45 cases ), The reference group given mothers oxytocin to prevent postpartum hemorrhage, the experimental group patients on the basis of this combination with misoprostol to prevent postpartum hemorrhage, compared with the actual effect of two patients. Results: The experimental group maternal treatment was significantly better than the reference group, significantly reduced uterine contractions, bleeding continued to decline. Conclusion: Misoprostol combined with oxytocin can effectively prevent postpartum hemorrhage, suggesting its clinical application.